You are here

  • Home
  • Archive
  • Volume 6, Issue 1
  • Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI

Article metrics

Article menu

Download PDFPDF

Spondyloarthritis
Original research
Eligibility criteria for biologic disease-modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI

 

Online download statistics by month:

Online download statistics by month: March 2020 to September 2024

AbstractFullPdf
Mar 2020241239109
Apr 202022122043
May 2020979719
Jun 2020727022
Jul 2020757514
Aug 2020515214
Sep 2020696812
Oct 2020858116
Nov 202073739
Dec 2020646313
Jan 2021737314
Feb 2021976315
Mar 20211099816
Apr 2021808118
May 2021656518
Jun 202170708
Jul 202159597
Aug 2021676613
Sep 202151506
Oct 2021484722
Nov 2021232320
Dec 202142433
Jan 202228292
Feb 202239418
Mar 2022505219
Apr 202250507
May 2022586419
Jun 2022494911
Jul 202236368
Aug 2022565716
Sep 2022565415
Oct 2022757917
Nov 202244446
Dec 2022373718
Jan 2023555612
Feb 2023686311
Mar 202351519
Apr 2023555515
May 2023646622
Jun 2023393877
Jul 2023444213
Aug 202332327
Sep 2023383612
Oct 2023454213
Nov 202354496
Dec 2023787812
Jan 202414142
Feb 202429283
Mar 2024515158
Apr 2024525032
May 2024444314
Jun 202443419
Jul 2024877918
Aug 202432256
Sep 202442448
Total34273351936